546 — Medtecs International Cashflow Statement
0.000.00%
Last trade - 00:00- SG$69.75m
- SG$63.83m
- $52.63m
- 43
- 49
- 44
- 39
Annual cashflow statement for Medtecs International, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1.52 | 135 | 16.9 | -30.7 | -22.6 |
| Depreciation | |||||
| Non-Cash Items | 2.52 | 1.75 | 2.86 | 15.1 | 9.24 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -5.47 | -43.2 | 3.8 | 5.21 | -1.69 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 4.37 | 102 | 30.1 | -4.05 | -7.99 |
| Capital Expenditures | -4.57 | -8.4 | -16.4 | -19.8 | -2.79 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.077 | 2.22 | 0.985 | -4.12 | 1.22 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -4.65 | -6.18 | -15.4 | -23.9 | -1.57 |
| Financing Cash Flow Items | -2.68 | -1.43 | 1.64 | -0.319 | -0.746 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.17 | -16.3 | -47.5 | -2.96 | 6.63 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.45 | 79.1 | -33.1 | -30.9 | -2.93 |